martes, 27 de marzo de 2018

CMS Issues New Guidance to Manufacturers regarding the updated National Drug Rebate Agreement
On March 23, 2018, the Centers for Medicare & Medicaid Services (CMS) published in the Federal Register the final notice for the Medicaid National Drug Rebate Agreement (NDRA) (83 FR 12770) that announced changes to the NDRA which were applicable as of the March 23, 2018 publication date. The Federal Notice is available at the following link:
On March 26, 2018, CMS released guidance to manufacturers through Manufacturer Release #108 which provides additional information to manufacturers as to the actions required for current manufacturers to remain active in the Medicaid Drug Rebate Program. The release is now available for download at the following link:

No hay comentarios: